Fenimore Christopher R. sold REGN
February 9, 2024 · Form 4 insider transaction
Fenimore Christopher R. sold 344 shares of Regeneron Pharmaceuticals, Inc. at $950.49 per share, a transaction worth $327.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
344
Price
$950.49
Total value
$327.0K
InsiderFenimore Christopher R.
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 9, 2024
Filing dateFebruary 12, 2024
Shares owned after18,947
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents volume-weighted average price of sales of 344 shares of Company stock on February 9, 2024 at prices ranging from $950.33 to $950.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 9, 2024 at each separate price.